Novartis Sues HHS After Drug Selected for Medicare Drug Price Negotiation
- September 08, 2023
Novartis Ag is the latest pharmaceutical manufacturer suing to block the new Medicare drug price negotiation program.
ARTICLE TAGS
You must be logged in to access this content.